Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1Burkitt Lymphoma 1

Interventions

Etoposide 5Rituximab 4Radiotherapy 4Methotrexate 4Cytarabine 4Cyclophosphamide 3Cisplatin 3Vincristine 2Specimen Handling 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Gemcitabine 2Fenretinide 2Doxorubicin 2Carmustine 2venetoclax 1tucatinib 1temsirolimus 1plerixafor 1pertuzumab 1palbociclib 1olaparib 1merphos 1liposomal amphotericin B 1ixabepilone 1ibrutinib 1ibritumomab tiuxetan 1fludarabine 1cobimetinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Non-Hodgkin × Radioimmunotherapy × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡